Doctors test personalized approach for rare nasal cancer
NCT ID NCT06069830
Summary
This study is testing whether using PET scan results and a blood test for Epstein-Barr virus (EBV) to guide treatment decisions can improve outcomes for people with a rare type of nasal lymphoma. After initial chemotherapy, patients will receive different treatment combinations based on their scan and blood test results. The goal is to see if this personalized approach helps control the cancer longer and improves survival rates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NK-T-CELL LYMPHOMA, EXTRANODAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin Hospital
RECRUITINGShanghai, Shanghai Municipality, 200020, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.